Fecal carriage of carbapenemase and AmpC-β-lactamase producers among extended spectrum β-Lactamase-producing E. coli and Klebsiella spp. isolates in patients attending hospitals | BMC Infectious Diseases

Understanding Carbapenemase and AmpC-β-Lactamase Production in Enterobacteriaceae

The prevalence of fecal carriage of carbapenemase and AmpC-β-lactamase in Enterobacterium spp. remains a critical issue in global health. Recent studies have shown varying rates of these resistant enzymes, with a notable presence in regions across Africa. For instance, studies from Gambia and Algeria report a prevalence similar to Burkina Faso.

Global Variations in Fecal Carriage

Different studies highlight how the prevalence rates of carbapenemase in countries like Burkina Faso, Egypt, and Gabon can exceed those in Ghana, Tunisia, and Morocco. This highlights the importance of local surveillance systems in addressing antibiotic resistance. For instance, recent studies in Tunisia and Morocco identified class D carbapenemase OXA-48 as predominant, whereas NDM class B was noted in India and Burkina Faso.

Risk Factors and Environmental Concerns

A major risk of disseminating carbapenemase-producing bacteria comes from infants and inpatients. Hospitals’ environments can become hotspots for transmission, with fecal contamination of water increasing the spread. A study from Cameroon referenced systematic reviews which emphasize this concern, especially in developing countries.

Future Trends in Antimicrobial Resistance

Antibiotic Resistance Patterns

High rates of resistance to ESBL inhibitors, aminoglycosides, and fluoroquinolones are becoming more concerning. Mixed resistance patterns, as seen in some African nations, show the urgency for improved infection control practices. Resistance rates to amoxicillin-clavulanic acid and piperacillin-tazobactam are alarming, particularly as these medications are primary treatments for bacterial infections.

The Role of Hospital Environments

Monitoring resistance in hospital settings is crucial. Hospitals can facilitate the cycle of resistance due to environmental contamination and confounding factors like inadequate wastewater management. Studies show high resistance to cephalosporin antibiotics among isolates from hospital wastewater, underscoring the need for

Leave a Comment